Cargando…

Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis

Background: The relative benefit of immediate complete revascularization, staged complete revascularization, and culprit-only percutaneous coronary intervention (PCI) remains unclear in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Kongyong, Yin, Dong, Zhu, Chenggang, Yuan, Sheng, Wu, Shaoyu, Feng, Lei, Dou, Kefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767564/
https://www.ncbi.nlm.nih.gov/pubmed/35071337
http://dx.doi.org/10.3389/fcvm.2021.695822
_version_ 1784634762333257728
author Cui, Kongyong
Yin, Dong
Zhu, Chenggang
Yuan, Sheng
Wu, Shaoyu
Feng, Lei
Dou, Kefei
author_facet Cui, Kongyong
Yin, Dong
Zhu, Chenggang
Yuan, Sheng
Wu, Shaoyu
Feng, Lei
Dou, Kefei
author_sort Cui, Kongyong
collection PubMed
description Background: The relative benefit of immediate complete revascularization, staged complete revascularization, and culprit-only percutaneous coronary intervention (PCI) remains unclear in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. The aim of this study was to compare the clinical outcomes of the 3 PCI strategies in this population. Methods: We followed a pre-specified protocol (PROSPERO number: CRD42020183801). A comprehensive search of the electronic databases including PubMed, EMBASE and Cochrane Library from inception through February 21, 2020 was conducted. Randomized trials evaluating the comparative efficacy and safety of at least 2 of the 3 PCI strategies were identified. The primary endpoint was the composite of cardiovascular mortality or myocardial infarction (MI) during the longest follow-up. Pairwise and network meta-analyses were performed with random-effects model. Results: Eleven trials including 6,942 patients were analyzed. Pairwise meta-analysis noted that immediate complete revascularization and staged complete revascularization were respectively associated with a 52 and 27% reduction in the risk of cardiovascular death or MI (relative risk [RR] 0.48, 95% confidence interval [CI] 0.32–0.73, I(2) = 0%; and RR 0.73, 95% CI 0.61–0.88, I(2) = 0%, respectively), compared with culprit-only PCI. The risk of cardiovascular death or MI was not statistically different in staged and immediate complete revascularization groups (RR 0.88, 95% CI 0.45–1.72, I(2) = 0%). Network meta-analysis obtained almost similar results compared with pairwise meta-analysis, and immediate complete revascularization had a 77% probability of being the best strategy for reducing cardiovascular death or MI among the 3 PCI strategies. Conclusion: The current evidence suggests that both immediate and staged complete revascularization were associated with a reduction of cardiovascular death or MI compared with culprit-only PCI. Further trials are warranted to directly compare immediate vs. staged complete revascularization in this population. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO [CRD42020183801].
format Online
Article
Text
id pubmed-8767564
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87675642022-01-20 Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis Cui, Kongyong Yin, Dong Zhu, Chenggang Yuan, Sheng Wu, Shaoyu Feng, Lei Dou, Kefei Front Cardiovasc Med Cardiovascular Medicine Background: The relative benefit of immediate complete revascularization, staged complete revascularization, and culprit-only percutaneous coronary intervention (PCI) remains unclear in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. The aim of this study was to compare the clinical outcomes of the 3 PCI strategies in this population. Methods: We followed a pre-specified protocol (PROSPERO number: CRD42020183801). A comprehensive search of the electronic databases including PubMed, EMBASE and Cochrane Library from inception through February 21, 2020 was conducted. Randomized trials evaluating the comparative efficacy and safety of at least 2 of the 3 PCI strategies were identified. The primary endpoint was the composite of cardiovascular mortality or myocardial infarction (MI) during the longest follow-up. Pairwise and network meta-analyses were performed with random-effects model. Results: Eleven trials including 6,942 patients were analyzed. Pairwise meta-analysis noted that immediate complete revascularization and staged complete revascularization were respectively associated with a 52 and 27% reduction in the risk of cardiovascular death or MI (relative risk [RR] 0.48, 95% confidence interval [CI] 0.32–0.73, I(2) = 0%; and RR 0.73, 95% CI 0.61–0.88, I(2) = 0%, respectively), compared with culprit-only PCI. The risk of cardiovascular death or MI was not statistically different in staged and immediate complete revascularization groups (RR 0.88, 95% CI 0.45–1.72, I(2) = 0%). Network meta-analysis obtained almost similar results compared with pairwise meta-analysis, and immediate complete revascularization had a 77% probability of being the best strategy for reducing cardiovascular death or MI among the 3 PCI strategies. Conclusion: The current evidence suggests that both immediate and staged complete revascularization were associated with a reduction of cardiovascular death or MI compared with culprit-only PCI. Further trials are warranted to directly compare immediate vs. staged complete revascularization in this population. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO [CRD42020183801]. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8767564/ /pubmed/35071337 http://dx.doi.org/10.3389/fcvm.2021.695822 Text en Copyright © 2022 Cui, Yin, Zhu, Yuan, Wu, Feng and Dou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Cui, Kongyong
Yin, Dong
Zhu, Chenggang
Yuan, Sheng
Wu, Shaoyu
Feng, Lei
Dou, Kefei
Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
title Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
title_full Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
title_fullStr Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
title_full_unstemmed Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
title_short Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
title_sort optimal revascularization strategy for patients with st-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767564/
https://www.ncbi.nlm.nih.gov/pubmed/35071337
http://dx.doi.org/10.3389/fcvm.2021.695822
work_keys_str_mv AT cuikongyong optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis
AT yindong optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis
AT zhuchenggang optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis
AT yuansheng optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis
AT wushaoyu optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis
AT fenglei optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis
AT doukefei optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis